Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Convertible Debt: 2010-2018

Historic Convertible Debt for Ani Pharmaceuticals (ANIP) over the last 7 years, with Dec 2018 value amounting to $112.5 million.

  • Ani Pharmaceuticals' Convertible Debt fell 12.33% to $117.6 million in Q3 2019 from the same period last year, while for Sep 2019 it was $117.6 million, marking a year-over-year decrease of 12.33%. This contributed to the annual value of $112.5 million for FY2018, which is 12.28% down from last year.
  • Ani Pharmaceuticals' Convertible Debt amounted to $112.5 million in FY2018, which was down 12.28% from $128.2 million recorded in FY2017.
  • Over the past 5 years, Ani Pharmaceuticals' Convertible Debt peaked at $128.2 million during FY2017, and registered a low of $106.5 million during FY2014.
  • Moreover, its 3-year median value for Convertible Debt was $120.6 million (2016), whereas its average is $120.4 million.
  • Per our database at Business Quant, Ani Pharmaceuticals' Convertible Debt climbed by 6.46% in 2015 and then declined by 12.28% in 2018.
  • Over the past 5 years, Ani Pharmaceuticals' Convertible Debt (Yearly) stood at $106.5 million in 2014, then increased by 6.46% to $113.4 million in 2015, then climbed by 6.36% to $120.6 million in 2016, then grew by 6.27% to $128.2 million in 2017, then decreased by 12.28% to $112.5 million in 2018.